Stocklytics Platform
Asset logo for symbol ABT
Abbott Laboratories
ABT51
$113.64arrow_drop_up0.07%$0.08
S&P500
Asset logo for symbol ABT
ABT51

$113.64

arrow_drop_up0.07%

Income Statement (ABT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT$918.00M$645.00M$1.86B$1.76B$1.66B
EBITDA$1.72B$1.45B$2.67B$2.59B$2.46B
gross Profit$5.80B$5.54B$5.25B$5.53B$5.49B
NET Income$1.30B$1.22B$1.59B$1.43B$1.37B
total Revenue$10.37B$9.96B$10.24B$10.14B$9.97B

Balance Sheet (ABT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents---$6.70B$7.83B
net Debt$7.76B$8.30B$8.97B$8.81B$9.01B
stockholders Equity$39.31B$38.81B$38.60B$37.48B$37.17B
total Assets$73.01B$72.46B$73.21B$72.09B$73.35B
total Debt$14.75B$14.58B$15.87B$15.52B$16.84B
total Liabilities$33.45B$33.42B$34.38B$34.39B$35.95B

Cash Flow (ABT)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow-$791.00M-$1.17B-$2.05B-$2.34B-$1.28B
free Cash Flow$1.42B$627.00M$2.28B$1.31B$696.00M
investing Cash Flow----$634.00M-$1.21B
operating Cash Flow$1.96B$1.02B$3.03B$1.87B$1.20B

Abbott Laboratories (ABT) Financials

Abbott Laboratories (ABT) is a multinational healthcare company that develops, manufactures, and sells a wide range of healthcare products. The company's income statement provides a snapshot of its financial performance over a specific period of time. It lists the company's revenues, expenses, and net income. Revenues represent the total amount of money generated from the sale of goods or services. Expenses include costs such as production costs, selling and administrative expenses, and taxes. Net income is the company's total revenue minus expenses and taxes. In recent years, Abbott Laboratories has consistently reported strong financial performance, with increasing revenues and net income.
One important measure of a company's profitability is its Earnings Before Interest and Taxes (EBIT). EBIT represents a company's operating income before deducting interest and taxes. It provides a measure of a company's ability to generate profits from its operations. Abbott Laboratories' EBIT has been steadily increasing over the years, reflecting the company's strong financial performance. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is another measure of a company's profitability. It provides a more comprehensive view of a company's profitability by excluding non-cash expenses such as depreciation and amortization. Abbott Laboratories has consistently reported solid EBITDA figures, indicating its ability to generate substantial cash flow from its operations.
add Abbott Laboratories to watchlist

Keep an eye on Abbott Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media